Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Funding awarded for research into zoonotic pig disease
Streptococcus suis can be transferred to humans who handle livestock.
Streptococcus suis can be fatal to pigs.

A group of scientists has received government funding to develop a vaccine to tackle the bacterial infection Streptococcus suis.

Streptococcus suis is a bacterial infection that can cause serious, and often fatal, disease in pigs. It can also be transferred to humans who handle infected livestock.

It is one of the more common diseases affecting the UK pig population, as well as affecting over 60 per cent of pig farms in countries across Europe.

There are currently no proven vaccines for tackling the various strains of the disease.

The UK government is aiming to achieve a 50 per cent reduction in antibiotic use in livestock by 2030. The goal forms part of a global drive to tackle the threat of antimicrobial resistance.

The Department of Environment, Food and Rural Affairs has now issued a £1m grant from its Farming Innovation Programme for the development of an effective vaccine against the disease.

The vaccine project is to be led by The Vaccine Group, the University of Plymouth and the University of Cambridge.

In previous research, the University of Cambridge and the University of Plymouth had identified a potential candidate for the Streptococcus suis vaccine. This vaccine would work by administering a harmless virus, which would generate a greater quantity of the proteins which induce an immune response.

The group will now investigate whether this existing vaccine candidate, which has been proven to be effective against a common strain of the disease, is also effective for use to protect pigs from multiple strains of the disease. By extension, this could prevent transmission to humans.

The research team will conduct trials in conjunction with animal health specialists from Moredun Scientific Ltd.

It will also engage directly with the pig farming community, ensuring the vaccine meets their requirements and can be administered in an efficient, cost-effective way.

Jeremy Salt, chief executive officer at The Vaccine Group, said: “As a zoonotic infection, there is also the risk of the disease being passed on to humans working in the industry.

“Our goal in developing an effective vaccine is stop the bacterial infection from developing in pigs and humans in the first place. By doing so, we can better protect the farmers, their animals and their livelihoods.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Antibiotic Amnesty survey opens

News Story 1
 The Responsible Use of Medicines Alliance - Companion Animal and Equine (RUMA - CA&E) has launched a survey which seeks to measure the success of this year's Antibiotic Amnesty campaign.

Its results will help the group to calculate how many unused or out-of-date antibiotics were returned as part of the campaign throughout November. Practices are also asked how they engaged with clients to raise awareness of the issue.

Participating practices can enter a prize draw to win up to 100 in vouchers for taking part. Further prizes from BSAVA and Webinar Vet will be available for practices with the best input.

The survey takes a few minutes to complete and will be running throughout December. It can be accessed via this link

Click here for more...
News Shorts
Bluetongue cases lead to restricted zone extension

Following the detection of new cases of bluetongue virus serotype 3 (BTV-3), the restricted zone has been extended to include additional parts of Hampshire, Wiltshire, Oxfordshire and North Yorkshire, as well as Bournemouth, Christchurch, Poole and part of Dorset.

The zone now covers 28 counties and unitary authorities in England. As of 16 December, 185 cases of BTV-3 have been confirmed in England and Wales during the current vector period.

Bluetongue is a notifiable disease. Suspected cases must be reported on 03000 200 301 in England or 03003 038 268 in Wales. In Scotland, suspected cases should be reported to the local field services office. Suspected cases in Northern Ireland should be reported to the DAERA Helpline on 0300 200 7840 or by contacting the local DAERA Direct Veterinary Office.

A map of the area where movement restrictions apply can be found here.